CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Pfizer Inc. v. Watson Pharmaceuticals Inc.

1:10-cv-00357

Overview

Case Number 1:10-cv-00357
Filing Date 2010-04-28
Status Terminated
Termination Date 2013-02-08
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Watson Laboratories Inc. - Florida Operating Company

Represented By

4 Attorneys Listed

Ranbaxy Pharmaceuticals Inc Operating Company

Represented By

6 Attorneys Listed

Watson Laboratories Inc. Operating Company

Represented By

5 Attorneys Listed

Ranbaxy Laboratories Limited NPE (University / Research)

Represented By

6 Attorneys Listed

Wyeth LLC Operating Company

Represented By

2 Attorneys Listed

Wyeth Pharmaceuticals, Inc. Operating Company

Represented By

2 Attorneys Listed

Pfizer Inc. Operating Company

Represented By

2 Attorneys Listed

Counter Claimant

Watson Pharma Inc. Operating Company

Represented By

4 Attorneys Listed

Watson Pharmaceuticals Inc. Operating Company

Represented By

4 Attorneys Listed

Ranbaxy Inc. Operating Company

Represented By

7 Attorneys Listed

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 16 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts Counterparts in force
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (16): 🇨🇦 Canada 🇩🇪 Germany 🇪🇺 Europe 🇯🇵 Japan KR 🇺🇸 US
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5100899
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
Filed: 1989-06-06
Issued: 1992-03-31
Expired (Term Ended) +1492d PTA
Expires: 2013-07-07

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1492 days) / Cellect Scrutiny — Over 1492 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

9

Dispositive

0

Granted

0

Denied

0

Pending / Review

9

Motions by Category

Procedural / Extension Motion 7 Claim Construction / Markman Filing 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for Watson's Post-Trial Reply Brief and Pfizer's Post-Trial Surreply Brief to July 13, 2012 and July 26, 2012, respectively - filed b...
Entry #170 • 2012-07-10 Document →
Procedural / Extension Motion Pending / Under Review
Joint STIPULATION TO EXTEND TIME to Amend the Second Amended Case Mangaement Order - filed by Pfizer Inc., Ranbaxy Inc., Ranbaxy Laboratories Limited, Ranbaxy P...
Entry #122 • 2011-10-07 Document →
Claim Construction / Markman Filing Pending / Under Review
Letter to The Honorable Legrome D. Davis from Frederick L. Cottrell, III regarding upcoming claim construction dates - re 62 Order, Set Scheduling Order Deadlin...
Entry #66 • 2011-06-06 Document →
Claim Construction / Markman Filing Pending / Under Review
ORDER- Upon consideration of the parties 60 REVISED Proposed Joint Scheduling Report and Discovery Plan, IT IS HEREBY ORDERED- (Joinder of Parties due by 4/29/2...
Entry #62 • 2011-04-26 Document →
Procedural / Extension Motion Pending / Under Review
ORDER - granting 51 Motion for Leave to File Second Amended Complaint. Signed by Judge Legrome D. Davis on 12/30/10. (rwc) (Entered: 01/03/2011)
Entry #52 • 2011-01-03 Document →
Procedural / Extension Motion Pending / Under Review
MOTION (Unopposed) for Leave to File Second Amended Complaint - filed by Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals, Inc.. (Attachments: # 1 Amended Pleading...
Entry #51 • 2010-12-17 Document →

Docket Entries

(203 total)
Pleading / Complaint

COMPLAINT filed against Ranbaxy Inc., Ranbaxy Laboratories Limited, Ranbaxy Pharmaceuticals Inc, Watson Laboratories Inc., Watson Laboratories Inc. - Florida, Watson Pharma Inc., Watson Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-726852.) - filed by Wyeth LLC, Pfizer Inc., Wyeth Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(ksr) (Entered: 04/29/2010)

Entry #1 • 2010-04-28
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (ksr) (Entered: 04/29/2010)

Entry #2 • 2010-04-28
1

Disclosure Statement pursuant to Rule 7.1 filed by Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals, Inc. identifying Corporate Parent Pfizer Inc. for Wyeth LLC; Corporate Parent Wyeth LLC for Wyeth Pharmaceuticals, Inc.. (ksr) (Entered: 04/29/2010)

Entry #8 • 2010-04-28
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,100,899; (ksr) (Entered: 04/29/2010)

Entry #3 • 2010-04-29
1
Pleading / Complaint

SUMMONS Returned Executed by Wyeth LLC, Pfizer Inc., Wyeth Pharmaceuticals, Inc.. Ranbaxy Inc. served on 4/28/2010, answer due 5/19/2010. (Blumenfeld, Jack) (Entered: 04/29/2010)

Entry #4 • 2010-04-29
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc